<DOC>
	<DOCNO>NCT02112942</DOCNO>
	<brief_summary>A multi-part study evaluate safety PK single ascending dos IDX21549 healthy HCV-infected subject . The effect food PK IDX21549 also evaluate . Antiviral activity also assess HCV-infected subject .</brief_summary>
	<brief_title>Study Assessing Single Multiple Doses IDX21459 Healthy HCV-Infected Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>All subject Subjects good general health . Subjects provide write informed consent form . All subject childbearing potential must agree use double method birth control ( one must barrier ) Screening least 90 day last dose study drug . HCV Subjects Documented clinical history compatible chronic hepatitis C without cirrhosis . Treatmentna√Øve HCV Genotype 1 All subject Pregnant breastfeeding Coinfected hepatitis B virus ( HBV ) and/or human immunodeficiency virus ( HIV ) . Decompensated liver disease Other clinically significant medical condition laboratory abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Hepatitis C virus</keyword>
	<keyword>HCV</keyword>
</DOC>